Syntone Ventures LLC - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 15, 2024, Syntone Ventures LLC's relationship to Outlook Therapeutics, Inc. (OTLK) is TenPercentOwner, and currently has 1,705,438 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other OTLK insiders.
Data Source: SEC.
Syntone Ventures LLC - Insider Non-Derivative Transactions at OTLK
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 16, 2024 | P -- (Common Stock) | 714286 | 0 | 1705438 |